Profile picture

Professor Marco Cattaneo

Milan (Italy)
Follow
Logo ESC

Contributor content

Switching from clopidogrel to prasugrel or ticagrelor: tips and tricks
Journal
Switching from clopidogrel to prasugrel or ticagrelor: tips and tricks
31 March 2016
Inhibition of the platelet P2Y<sub>12</sub> receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A<sub>2</sub>
Journal
Inhibition of the platelet P2Y<sub>12</sub> receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A<sub>2</sub>
29 October 2015
Fast, potent, and reliable inhibition of platelet aggregation
Journal
Fast, potent, and reliable inhibition of platelet aggregation
1 December 2009
Advances in antiplatelet therapy: overview of new P2Y<sub>12</sub> receptor antagonists in development
Journal
Advances in antiplatelet therapy: overview of new P2Y<sub>12</sub> receptor antagonists in development
1 November 2008
Laboratory detection of ‘aspirin resistance’: what test should we use (if any)? The opinions expressed in this article are necessarily not those of the Editors of <em>European Heart Journal</em> or of the European Society of Cardiology.
Journal
Laboratory detection of ‘aspirin resistance’: what test should we use (if any)? The opinions expressed in this article are necessarily not those of the Editors of <em>European Heart Journal</em> or of the European Society of Cardiology.
22 June 2007
P2Y<sub>12</sub> receptor antagonists: a rapidly expanding group of antiplatelet agentsThe opinions expressed in this article are not necessarily those of the Editors of the <em>European Heart Journal</em> or of the European Society of Cardiology.
Journal
P2Y<sub>12</sub> receptor antagonists: a rapidly expanding group of antiplatelet agentsThe opinions expressed in this article are not necessarily those of the Editors of the <em>European Heart Journal</em> or of the European Society of Cardiology.
28 March 2006